US09058V1035 - BCRX - 896047 (XNAS)
BIOCRYST PHARMACEUTICALS INC Aktie
8,06 USD
Aktuelle Kurse von BIOCRYST PHARMACEUTICALS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
BCRX
|
USD
|
20.09.2024 00:25
|
8,06 USD
| 8,15 USD | -1,07 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 2,32 % | 4,04 % | 34,39 % | 50,43 % | 5,40 % | 178,04 % |
Firmenprofil zu BIOCRYST PHARMACEUTICALS INC Aktie
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Investierte Fonds
Folgende Fonds haben in BIOCRYST PHARMACEUTICALS INC investiert:
Fonds | Vol. in Mio 92,09 | Anteil (%) 0,22 % |
Unternehmensdaten zur BIOCRYST PHARMACEUTICALS INC Aktie
Name BIOCRYST PHARMACEUTICALS INC
Firma BioCryst Pharmaceuticals, Inc.
Symbol BCRX
Website https://www.biocryst.com
Heimatbörse
NASDAQ
WKN 896047
ISIN US09058V1035
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Jon P. Stonehouse
Marktkapitalisierung 2 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,5 T
Adresse 4505 Emperor Boulevard, 27703 Durham
IPO Datum 1994-03-04
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | BO1.F |
NASDAQ | BCRX |
Weitere Aktien
Investoren die BIOCRYST PHARMACEUTICALS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024